Biologic interventions in rheumatoid arthritis

J. J. Cush, A. F. Kavanaugh

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

An increasing understanding of the immunopathogenesis of rheumatoid arthritis and advances in biotechnology have lead to the therapeutic application of immune-specific interventions. The complexity of this disorder has generated numerous investigations using a wide range of biologic interventions. This article presents the current and potential targets for such biopharmaceutical agents and discusses their utility in rheumatoid arthritis.

Original languageEnglish (US)
Pages (from-to)797-816
Number of pages20
JournalRheumatic Disease Clinics of North America
Volume21
Issue number3
StatePublished - Jan 1 1995

Fingerprint

Rheumatoid Arthritis
Biotechnology
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

Biologic interventions in rheumatoid arthritis. / Cush, J. J.; Kavanaugh, A. F.

In: Rheumatic Disease Clinics of North America, Vol. 21, No. 3, 01.01.1995, p. 797-816.

Research output: Contribution to journalReview article

@article{d0e5e0595298417b8884829166a9222c,
title = "Biologic interventions in rheumatoid arthritis",
abstract = "An increasing understanding of the immunopathogenesis of rheumatoid arthritis and advances in biotechnology have lead to the therapeutic application of immune-specific interventions. The complexity of this disorder has generated numerous investigations using a wide range of biologic interventions. This article presents the current and potential targets for such biopharmaceutical agents and discusses their utility in rheumatoid arthritis.",
author = "Cush, {J. J.} and Kavanaugh, {A. F.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "21",
pages = "797--816",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Biologic interventions in rheumatoid arthritis

AU - Cush, J. J.

AU - Kavanaugh, A. F.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - An increasing understanding of the immunopathogenesis of rheumatoid arthritis and advances in biotechnology have lead to the therapeutic application of immune-specific interventions. The complexity of this disorder has generated numerous investigations using a wide range of biologic interventions. This article presents the current and potential targets for such biopharmaceutical agents and discusses their utility in rheumatoid arthritis.

AB - An increasing understanding of the immunopathogenesis of rheumatoid arthritis and advances in biotechnology have lead to the therapeutic application of immune-specific interventions. The complexity of this disorder has generated numerous investigations using a wide range of biologic interventions. This article presents the current and potential targets for such biopharmaceutical agents and discusses their utility in rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=0029119187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029119187&partnerID=8YFLogxK

M3 - Review article

C2 - 8619100

AN - SCOPUS:0029119187

VL - 21

SP - 797

EP - 816

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 3

ER -